Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.

Earlier this year, biotech company 23andMe filed for bankruptcy. The harsh reality was that its business, while enticing to people who wanted to learn about their backgrounds via DNA testing kits

Is Amgen Stock a Buy?
Is Amgen Stock a Buy?

Amgen (NASDAQ: AMGN) is doing something unusual in 2025. The biotech giant's shares are up 7.2% for the year as I write this while most large-cap healthcare stocks struggle; yet it trades at just 13

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

The three major indexes slid in March and April as investors worried about the impact of President Donald Trump's import tariffs on the economy -- but in recent weeks, optimism about lower, more

Is Pfizer Stock a Buy After This $1.25 Billion Investment?
Is Pfizer Stock a Buy After This $1.25 Billion Investment?

Pfizer (NYSE: PFE) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the biopharmaceutical industry to generate $100 billion in annual sales.

However

Down 63%, Should You Buy the Dip on Pfizer?
Down 63%, Should You Buy the Dip on Pfizer?

It's been a tough go for Pfizer (NYSE: PFE). Shares of the pharmaceutical giant are down over 60% from their highs, a multi-year slide since pandemic-related sales peaked a few years ago. But that's

The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now

The stock market is anything but normal right now. Not even halfway through the year, the broader benchmark S&P 500 index fell nearly 20% from highs made in February, only to make a full recovery

Does the 23andMe Acquisition Make Regeneron a Buy Now?
Does the 23andMe Acquisition Make Regeneron a Buy Now?

Have you ever wondered if an established drugmaker could do better at genetics-guided research than a consumer-focused diagnostics business? Well, we could find out.

Recently, Regeneron (NASDAQ:

1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist
1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist

Most people like to buy products when prices are cheaper. That's why you'll probably see lots of car dealers, furniture stores, and retailers advertising special sales during the Memorial Day

Pfizer Stock Analysis: Buy, Sell, or Hold?
Pfizer Stock Analysis: Buy, Sell, or Hold?

Pfizer's (NYSE: PFE) management team is confident in its 2025 opportunities.

*Stock prices used were the afternoon prices of May 20, 2025. The video was published on May 22, 2025.

Continue reading

2 Dividend Stocks to Buy With $500 and Hold Forever
2 Dividend Stocks to Buy With $500 and Hold Forever

Broader equities have been volatile this year, but that's par for the course. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest. However

This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row
This Healthy High-Yielding Dividend Stock Just Increased Its Payment for the 48th Year in a Row

Medtronic (NYSE: MDT) has been a dividend stalwart for decades. The medical device maker recently raised its dividend payment, extending its growth streak to 48 straight years. That means it is two

Better Weight Loss Stock: Amgen or Viking Therapeutics?
Better Weight Loss Stock: Amgen or Viking Therapeutics?

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders in this area, Eli Lilly and Novo Nordisk. However, several other

Why Did UnitedHealth CEO Andrew Witty Resign?
Why Did UnitedHealth CEO Andrew Witty Resign?

These are the reasons that led to the resignation of UnitedHealth (NYSE: UNH) CEO Andrew Witty.

*Stock prices used were the afternoon prices of May 19, 2025. The video was published on May 21, 2025.

Why UnitedHealth Stock Sank Again Today
Why UnitedHealth Stock Sank Again Today

Shares of UnitedHealth Group (NYSE: UNH) plummeted again on Wednesday. The company's stock is down 5.8% as of market close, while the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX:

Here's What You Need to Know Before Buying or Selling United Health Stock
Here's What You Need to Know Before Buying or Selling United Health Stock

UnitedHealth (NYSE: UNH) is capturing investors' attention because of the massive changes surrounding the company.

*Stock prices used were the afternoon prices of May 18, 2025. The video was

2 High-Yield Dividend Stocks to Buy Right Now
2 High-Yield Dividend Stocks to Buy Right Now

Though there are plenty of dividend stocks on the market, they aren't all created equal. Consider that the average dividend yield for the S&P 500 (SNPINDEX: ^GSPC) is 1.3%, which is not particularly

The Best Healthcare Stocks: UnitedHealth Stock vs. CVS Stock
The Best Healthcare Stocks: UnitedHealth Stock vs. CVS Stock

UnitedHealth (NYSE: UNH) and CVS (NYSE: CVS) are facing headwinds in the healthcare industry that are unique and shared.

*Stock prices used were the afternoon prices of May 18, 2025. The video was

What's Going on With UnitedHealth Stock?
What's Going on With UnitedHealth Stock?

UnitedHealth (NYSE: UNH) stock is down considerably from its highs, and the company is facing several challenges simultaneously.

*Stock prices used were the afternoon prices of May 16, 2025. The

UnitedHealth Group Stock Just Hit a 5-Year Low. 5 Things Investors Need to Know.
UnitedHealth Group Stock Just Hit a 5-Year Low. 5 Things Investors Need to Know.

Few stocks have been as resilient as UnitedHealth Group (NYSE: UNH). The company operates the largest health insurance business in the U.S. It runs the second biggest pharmacy benefits manager

Should You Buy UnitedHealth Group Stock Now?
Should You Buy UnitedHealth Group Stock Now?

In this video, I will talk about the recent updates regarding UnitedHealth Group (NYSE: UNH). Watch the short video to learn more, consider subscribing, and click the special offer link below.

Deckers Stock Is Among the Worst Performers in the S&P 500 in 2025. Should Investors Buy the Dip?
Deckers Stock Is Among the Worst Performers in the S&P 500 in 2025. Should Investors Buy the Dip?

Shares of shoe company Deckers Outdoor (NYSE: DECK) are down about 37% in 2025, as of this writing, giving it the third worst performance for a constituent of the S&P 500. It only trails Moderna and

Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.
Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.

Dividend stocks can be a smart way to generate steady income, especially in uncertain markets. However, not all dividend payers are created equal. A recent study from Ned Davis Research and Hartford

Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years

Despite making significant clinical progress, CRISPR Therapeutics (NASDAQ: CRSP) has been struggling financially in the past three years. The company's shares are down by 24% over this period, while

Massive News for UnitedHealth Stock Investors!
Massive News for UnitedHealth Stock Investors!

UnitedHealth (NYSE: UNH) is reportedly under criminal investigation, and in this video, I will discuss what that could mean for investors.

*Stock prices used were the afternoon prices of May 14

3 Magnificent Stocks That Are Passive Income Machines
3 Magnificent Stocks That Are Passive Income Machines

Make money without even trying: That's what passive income is all about. But good investment alternatives are required to make this "easy" money.

Three Motley Fool contributors believe they have